Trauner, Michael

Will we ever model PSC? – “It's hard to be a PSC model!”

Pollheimer, M. J., Trauner, M., & Fickert, P. (2011) · Clinics and Research in Hepatology and Gastroenterology

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 66

24-Norursodeoxycholic acid reshapes immunometabolism in CD8(+) T cells and alleviates hepatic inflammation

Zhu, C., Boucheron, N., Müller, A. C., Májek, P., Claudel, T., Halilbasic, E., Baazim, H., Lercher, A., Viczenczova, C., Hainberger, D., et al. (2021) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 65

Nor-Ursodeoxycholic acid as a novel therapeutic approach for cholestatic and metabolic liver diseases

Halilbasic, E., Steinacher, D., & Trauner, M. (2017) · Digestive Diseases

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 55

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

Blokker, B. A., Maijo, M., Echeandia, M., Galduroz, M., Patterson, A. M., Ten, A., Philo, M., Schungel, R., Gutierrez‐de Juan, V., Halilbasic, E., et al. (2019) · Hepatology

Sirtuins and Resveratrol in MedicineLiver physiology and pathology

Cited by 46

Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension

Paternostro, R., Bardach, C., Hofer, B. S., Scheiner, B., Schwabl, P., Asenbaum, U., Ba‐Ssalamah, A., Scharitzer, M., Bucscis, T., Simbrunner, B., et al. (2021) · Liver International

Liver Disease and TransplantationNutrition and Health in Aging

Cited by 46

Nuclear receptors in liver fibrosis

Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 45

Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-κB: New insights into hepatic inflammation

Wagner, M., Zollner, G., & Trauner, M. (2008) · Hepatology

Drug Transport and Resistance MechanismsLiver physiology and pathology

Cited by 40

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis

Pollheimer, M. J., Racedo, S., Mikels-Vigdal, A., Marshall, D., Bowlus, C., Lackner, C., Madl, T., Karlsen, T. H., Hov, J. R., Lyman, S. K., et al. (2018) · Journal of Hepatology

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 38

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

Jones, D. E. J., Beuers, U., Bonder, A., Carbone, M., Culver, E., Dyson, J., Gish, R. G., Hansen, B. E., Hirschfield, G., Jones, R., et al. (2024) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

PNPLA3 I148M variant impairs liver X receptor signaling and cholesterol homeostasis in human hepatic stellate cells

Bruschi, F. V., Claudel, T., Tardelli, M., Starlinger, P., Marra, F., & Trauner, M. (2019) · Hepatology Communications

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 38

Fibrate treatment for primary biliary cirrhosis

Cuperus, F. J. C., Halilbasic, E., & Trauner, M. (2014) · Current Opinion in Gastroenterology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 36

Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information

Stift, J., Semmler, G., Walzel, C., Mandorfer, M., Schwarzer, R., Schwabl, P., Paternostro, R., Scheiner, B., Wöran, K., Pinter, M., et al. (2019) · Digestive and Liver Disease

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 34

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials

Wong, V. W.-S., Tak, W. Y., Goh, G. B. B., Cheng, P.-N., Lawitz, E. J., Younossi, Z. M., Vuppalanchi, R., Younes, Z., Alkhouri, N., Wang, L., et al. (2023) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 31

The new therapeutic frontier--nuclear receptors and the liver

Karpen, S. J., & Trauner, M. (2010) · Journal of Hepatology

Liver physiology and pathologyPeroxisome Proliferator-Activated Receptors

Cited by 29

A Fibrosis-Independent hepatic transcriptomic signature identifies drivers of disease progression in primary sclerosing cholangitis

Gindin, Y., Chung, C., Jiang, Z., Zhou, J. Z., Xu, J., Billin, A. N., Myers, R. P., Goodman, Z., Landi, A., Houghton, M., et al. (2021) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 23

Liver Capsule: FXR agonists against liver disease

Fuchs, C. D., Schwabl, P., Reiberger, T., & Trauner, M. (2016) · Hepatology

Drug Transport and Resistance MechanismsLiver Disease Diagnosis and Treatment

Cited by 20

Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Stift, J., Semmler, G., Wöran, K., Simbrunner, B., Scheiner, B., Schwabl, P., Paternostro, R., Pinter, M., Stättermayer, A. F., Meischl, T., et al. (2020) · Digestive and Liver Disease

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 16